TY  - JOUR
AU  - Sivelli, Francesco
AU  - Rossi, Elio
AU  - Baccetti, Sonia
AU  - Di Stefano, Mariella
AU  - Gallo, Eugenia
AU  - Firenzuoli, Fabio
PY  - 2019
DA  - 2019/10/18
TI  - Herb-Drug Interactions in Oncology: A Clinical Up-Date
JO  - OBM Integrative and Complementary Medicine
SP  - 060
VL  - 04
IS  - 04
AB  - Phytotherapy, which is defined as the use of titrated herbal extracts in clinical practice, has been receiving increasing interest in the scientific community recently. In the present report, information regarding the most important mechanisms underlying the drug-drug interactions (DDI) and herb-drug interactions (HDI) has been discussed briefly. Furthermore, the best known and relevant interactions of Ginkgo biloba, Citrus paradisi (Grapefruit Juice), Silybum marianum (Milk Thistle), Hypericum perforatum (St. John Wort) and Camellia sinensis (Green Tea) that have emerged from clinical evidence have been listed. The last part of the present report has been dedicated to cancer patients, with a summary of interactions between plants and drugs/chemotherapeutics. The “Reversed Grading for clinical risk of interactions in oncology”, a tool conceived by the Tuscan Network of Integrative Medicine, has also been reported.
SN  - 2573-4393
UR  - https://doi.org/10.21926/obm.icm.1904060
DO  - 10.21926/obm.icm.1904060
ID  - Sivelli2019
ER  -